BlackRock, Inc. 13D and 13G filings for Cardiovascular Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII | BlackRock Inc. BLK | 7,895,902 18.900% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Cardiovascular Systems, Inc. CSII | BlackRock Inc. BLK | 7,895,902 18.900% | 888,638 (+12.68%) | Filing |
| 2022-01-28 1:54 pm Purchase | 2021-12-31 | 13G | Cardiovascular Systems, Inc. CSII | BlackRock Inc. BLK | 7,007,264 17.300% | 37,375 (+0.54%) | Filing |
| 2021-01-25 4:49 pm Purchase | 2020-12-31 | 13G | Cardiovascular Systems, Inc. CSII | BlackRock Inc. BLK | 6,969,889 17.400% | 1,538,760 (+28.33%) | Filing |